Diet and inflammation in Alzheimer's disease and related chronic diseases: A review

Journal of Alzheimer's Disease

Volumn 50, Issue 2, 2016, Pages 301-334

  Gardener, Samantha L ^a,b   Rainey Smith, Stephanie R ^a,b   Martins, Ralph N ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; cardiovascular disease; curcumin; diabetes; diet; docosahexaenoic acid; eicosapentaenoic acid; flavonoids; inflammation; obesity

Indexed keywords

FLAVONOID;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DEGENERATIVE DISEASE; DIET THERAPY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; FAT INTAKE; HUMAN; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPICE; DIET; PATHOLOGY;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIET; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES;

EID: 84970917706     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150765     Document Type: Review

References (249)

1. Rozemuller AJ, van Gool WA, Eikelenboom P. (2005). The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: Therapeutic implications. Curr Drug Targets CNS Neurol Disord 4, 223-233
2. Schwab C, McGeer PL. (2008). Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369
3. Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. (2010). Neuroinflammation-An early event in both the history and pathogenesis of Alzheimer's disease. Neurodegener Dis 7, 38-41
4. Berg AH, Scherer PE. (2005). Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939-949
5. Paquette DW, Brodala N, Nichols TC. (2007). Cardiovascular disease, inflammation, and periodontal infection. Periodontol 2000 44, 113-126
6. Wellen KE, Hotamisligil GS. (2005). Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119
7. Hotamisligil GS. (2003). Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3), S53-S55
8. Navarro JF, Mora C. (2006). Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. ScientificWorldJournal 6, 908-917
9. Casserly I, Topol E. (2004). Convergence of atherosclerosis and Alzheimer's disease: Inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139-1146
10. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. BMJ 322, 1447-1451
11. Breteler MM. (2000). Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 21, 153-160
12. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I. (2002). Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453
13. Luchsinger JA, Mayeux R. (2004). Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6, 261-266
14. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A. (2005). Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560
15. Profenno LA, Porsteinsson AP, Faraone SV. (2010). Metaanalysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67, 505-512
16. Cavaillon JM, Annane D. (2006). Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12, 151-170
17. Kang NJ, Lee KW, Lee DE, Rogozin EA, Bode AM, Lee HJ, Dong Z. (2008). Cocoa procyanidins suppress transformation by inhibiting mitogen-Activated protein kinase kinase. J Biol Chem 283, 20664-20673
18. Barnes PJ, Karin M. (1997). Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336, 1066-1071
19. Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, Isakson P. (1995). Mediation of inflammation by cyclooxygenase-2. Agents Actions Suppl 46, 41-50
20. Kim YS, Young MR, Bobe G, Colburn NH, Milner JA. (2009). Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila) 2, 200-208
21. Berger J, Moller DE. (2002). The mechanisms of action of PPARs. Annu Rev Med 53, 409-435
22. Chan MM. (1995). Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49, 1551-1556
23. Aggarwal BB, Kumar A, Bharti AC. (2003). Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23, 363-398
24. Singh S, Aggarwal BB. (1995). Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24995-25000
25. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 98, 3410-3415
26. Zhao G, Etherton TD, Martin KR, Vanden Heuvel JP, Gillies PJ, West SG, Kris-Etherton PM. (2005). Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336, 909-917
27. Chapkin RS, Akoh CC, Miller CC. (1991). Influence of dietary n-3 fatty acids on macrophage glycerophospholipid molecular species and peptidoleukotriene synthesis. J Lipid Res 32, 1205-1213
28. Yaqoob P, Calder P. (1995). Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 163, 120-128
29. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, 3rd, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF. (1985). Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312, 1217-1224
30. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Sheldon M, Wolff MD, Dinarello CA. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320, 265-271
31. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. (1993). Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91, 651-660
32. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. (2004). Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79, 606-612
33. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, Hebert JR. (2009). A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr 139, 2365-2372
34. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR. (2014). Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr 17, 1689-1696
35. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. (2007). Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NFkappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflam 2007, 45673
36. Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, Kohli K. (2009). Mechanism of action of flavonoids as anti-inflammatory agents: A review. Inflamm Allergy Drug Targets 8, 229-235
37. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. (2009). Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm Res 58, 537-552
38. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. (2001). Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 74, 418-425
39. Kim HP, Son KH, Chang HW, Kang SS. (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96, 229-245
40. Middleton E Jr, Kandaswami C, Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751
41. Robak J, Gryglewski RJ. (1988). Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37, 837-841
42. Valles SL, Dolz-Gaiton P, Gambini J, Borras C, Lloret A, Pallardo FV, Vina J. (2010). Estradiol or genistein prevent Alzheimer's disease-Associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res 1312, 138-144
43. Sharma V, Mishra M, Ghosh S, Tewari R, Basu A, Seth P, Sen E. (2007). Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection. Brain Res Bull 73, 55-63
44. Karlsen A, Retterstol L, Laake P, Paur I, Bohn SK, Sandvik L, Blomhoff R. (2007). Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 137, 1951-1954
45. Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE. (2006). Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 136, 981-986
46. Chun OK, Chung SJ, Claycombe KJ, Song WO. (2008). Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138, 753-760
47. Nieman DC, Henson DA, Davis JM, Angela Murphy E, Jenkins DP, Gross SJ, Carmichael MD, Quindry JC, Dumke CL, Utter AC, McAnulty SR, McAnulty LS, Triplett NT, Mayer EP. (2007). Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol. (1985). 103, 1728-1735
48. D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F. (2005). The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84, 474-477
49. Yildiz MF, Kumru S, Godekmerdan A, Kutlu S. (2005). Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet 90, 128-133
50. Hall WL, Vafeiadou K, Hallund J, Bugel S, Koebnick C, Reimann M, Ferrari M, Branca F, Talbot D, Dadd T, Nilsson M, Dahlman-Wright K, Gustafsson JA, Minihane AM, Williams CM. (2005). Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: Interactions with genotype and equol production. Am J Clin Nutr 82, 1260-1268; quiz 1365-1266
51. Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O. (2003). Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88, 5180-5185
52. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. (2003). Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78, 123-130
53. Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, Hu FB, van Dam RM. (2011). Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr 141, 618-625
54. Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT. (2009). Flavonoids and cognitive function: A review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr 4, 227-242
55. Rendeiro C, Vauzour D, Rattray M, Waffo-Teguo P, Merillon JM, Butler LT, Williams CM, Spencer JP. (2013). Dietary levels of pure flavonoids improve spatial memory performance and increase hippocampal brain-derived neurotrophic factor. PLoS One 8, e63535
56. Casadesus G, Shukitt-Hale B, Stellwagen HM, Zhu X, Lee HG, Smith MA, Joseph JA. (2004). Modulation of hippocampal plasticity and cognitive behavior by short-Term blueberry supplementation in aged rats. Nutr Neurosci 7, 309-316
57. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC. (1999). Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114-8121
58. Krikorian R, Shidler MD, Nash TA, Kalt W, Vinqvist-Tymchuk MR, Shukitt-Hale B, Joseph JA. (2010). Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 3996-4000
59. Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, Whiteman M, Spencer JP. (2008). Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 45, 295-305
60. Maher P, Akaishi T, Abe K. (2006). Flavonoid fisetin promotes ERK-dependent long-Term potentiation and enhances memory. Proc Natl Acad Sci U S A 103, 16568-16573
61. Kim HJ, Song JY, Park HJ, Park HK, Yun DH, Chung JH. (2009). Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Korean J Physiol Pharmacol 13, 281-285
62. Shiratori K, Ohgami K, Ilieva I, Jin XH, Yoshida K, Kase S, Ohno S. (2005). The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther 21, 298-304
63. Wang D, Gao K, Li X, Shen X, Zhang X, Ma C, Qin C, Zhang L. (2012). Long-Term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease. Pharmacol Biochem Behav 102, 13-20
64. Zhang ZJ, Cheang LC, Wang MW, Lee SM. (2011). Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med 27, 195-203
65. Onozuka H, Nakajima A, Matsuzaki K, Shin RW, Ogino K, Saigusa D, Tetsu N, Yokosuka A, Sashida Y, Mimaki Y, Yamakuni T, Ohizumi Y. (2008). Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 326, 739-744
66. Patil CS, Singh VP, Satyanarayan PS, Jain NK, Singh A, Kulkarni SK. (2003). Protective effect of flavonoids against aging-And lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 69, 59-67
67. Galli RL, Bielinski DF, Szprengiel A, Shukitt-Hale B, Joseph JA. (2006). Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiol Aging 27, 344-350
68. Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M. (2008). Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16, 2081-2087
69. Terra X, Pallares V, Ardevol A, Blade C, Fernandez-Larrea J, Pujadas G, Salvado J, Arola L, Blay M. (2011). Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J Nutr Biochem 22, 380-387
70. Tsuda T. (2008). Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J Agric Food Chem 56, 642-646
71. Chan MM, Ho CT, Huang HI. (1995). Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. Cancer Lett 96, 23-29
72. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS (2008)Themajorgreen tea polyphenol, (-)-βepigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677-1683
73. Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. (2013). Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: Effect on low grade inflammation. PLoS One 8, e63784
74. Tsai SJ, Huang CS, Mong MC, Kam WY, Huang HY, Yin MC. (2012). Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J Agric Food Chem 60, 514-521
75. Beking K, Vieira A. (2010). Flavonoid intake and disabilityadjusted life years due to Alzheimer's and related dementias: A population-based study involving twenty-Three developed countries. Public Health Nutr 13, 1403-1409
76. Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD. (2009). Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 139, 120-127
77. Ng TP, Feng L, Niti M, Kua EH, Yap KB. (2008). Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88, 224-231
78. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. (2012). Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95, 454-464
79. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. (2002). Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76, 560-568
80. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. (2007). Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr 85, 895-909
81. Sesso HD, Gaziano JM, Liu S, Buring JE. (2003). Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 77, 1400-1408
82. Kar P, Laight D, Rooprai HK, Shaw KM, Cummings M. (2009). Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: Adouble blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med 26, 526-531
83. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, Esposito K, Jonsson LS, Kolb H, Lansink M, Marcos A, Margioris A, Matusheski N, Nordmann H, O'Brien J, Pugliese G, Rizkalla S, Schalkwijk C, Tuomilehto J, Warnberg J, Watzl B, Winklhofer-Roob BM. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 106(Suppl 3), S5-78
84. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ. (2004). Midlife dietary intake of antioxidants and risk of latelife incident dementia: The Honolulu-Asia Aging Study. Am J Epidemiol 159, 959-967
85. Nagao T, Hase T, Tokimitsu I. (2007). A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15, 1473-1483
86. Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ. (2011). Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27, 206-213
87. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. (2006). Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356-358
88. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. (2005). Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: A prospective study and crosssectional analysis. J Am Coll Nutr 24, 376-384
89. Nettleton JA, Harnack LJ, Scrafford CG, Mink PJ, Barraj LM, Jacobs DR Jr. (2006). Dietary flavonoids and flavonoidrich foods are not associated with risk of type 2 diabetes in postmenopausal women. J Nutr 136, 3039-3045
90. Chainani-Wu N. (2003). Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med 9, 161-168
91. Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicano M, Rizzo C, Scapagnini G, Vasto S. (2010). Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: Therapeutic implications. Rejuvenation Res 13, 301-313
92. Chan MM, Huang HI, Fenton MR, Fong D. (1998). In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55, 1955-1962
93. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370-8377
94. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA. (2008). Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326, 196-208
95. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102, 1095-1104
96. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. (2006). Curry consumption and cognitive function in the elderly. Am J Epidemiol 164, 898-906
97. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. (2012). Oral curcumin for Alzheimer's disease: Tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4, 43
98. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V. (2008). Six-month randomized, placebo controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28, 110-113
99. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK, Yu R. (2007). Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci 80, 926-931
100. Weisberg SP, Leibel R, Tortoriello DV. (2008). Dietary curcumin significantly improves obesity-Associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149, 3549-3558
101. Jain SK, Rains J, Croad J, Larson B, Jones K. (2009). Curcumin supplementation lowers TNF-Alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-Treated cultured monocytes and blood levels of TNF-Alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 11, 241-249
102. Baldasseroni S, Mannucci E, Orso F, Di Serio C, Pratesi A, Bartoli N, Marella GA, Colombi C, Foschini A, Valoti P, Mossello E, Fumagalli S, Marchionni N, Tarantini F. (2012). Adiponectin in outpatients with coronary artery disease: Independent predictors and relationship with heart failure. Nutr Metab Cardiovasc Dis 22, 292-299
103. Cheng WW, Li YS, Gong XW, Zhao LL, Wang JG, Deng P, Jiang Y. (2008). Construction of different mutants of HAtagged human RAGE gene and their eukaryotic expression. Nan Fang Yi Ke Da Xue Xue Bao 28, 1779-1781
104. Kwon HK, Hwang JS, So JS, Lee CG, Sahoo A, Ryu JH, Jeon WK, Ko BS, Im CR, Lee SH, Park ZY, Im SH. (2010). Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 10, 392
105. Boulanger E, Daroux M. (2008). Peritoneal aging during PD: Implication of RAGE, the receptor for AGEs. Nefrologia 28(Suppl 6), 5-10
106. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M. (2011). Orally administrated cinnamon extract reduces beta-Amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One 6, e16564
107. Ho SC, Chang KS, Chang PW. (2013). Inhibition of neuroinflammation by cinnamon and its main components. Food Chem 138, 2275-2282
108. Cao H, Anderson RA. (2011). Cinnamon polyphenol extract regulates tristetraprolin and related gene expression in mouse adipocytes. J Agric Food Chem 59, 2739-2744
109. Grzanna R, Lindmark L, Frondoza CG. (2005). Ginger- an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8, 125-132
110. Kiuchi F, Shibuya M, Sankawa U. (1982). Inhibitors of prostaglandin biosynthesis from ginger. Chem Pharm Bull (Tokyo) 30, 754-757
111. Srivastava KC. (1986). Isolation and effects of some ginger components of platelet aggregation and eicosanoid biosynthesis. Prostaglandins Leukot Med 25, 187-198
112. Flynn DL, Rafferty MF, Boctor AM. (1986). Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med 24, 195-198
113. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. (2004). Ginger extract inhibits beta-Amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 10, 1009-1013
114. Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS, Lindmark L. (2004). An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cell Dev Biol Anim 40, 95-101
115. Tripathi S, Bruch D, Kittur DS. (2008). Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 8, 1
116. Zeng GF, Zhang ZY, Lu L, Xiao DQ, Zong SH, He JM. (2013). Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Res 16, 124-133
117. Mathew M, Subramanian S. (2014). In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract. Indian J Exp Biol 52, 606-612
118. Wattanathorn J, Jittiwat J, Tongun T, Muchimapura S, Ingkaninan K. (2011). Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat. Evid Based Complement Alternat Med 2011, 429505
119. Kim DS, Kim JY, Han YS. (2007). Alzheimer's disease drug discovery from herbs: Neuroprotectivity from beta-Amyloid (1-42) insult. J Altern Complement Med 13, 333-340
120. Wang JP, Hsu MF, Teng CM. (1984). Antiplatelet effect of capsaicin. Thromb Res 36, 497-507
121. Jungbauer A, Medjakovic S. (2012). Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. Maturitas 71, 227-239
122. Yu Q, Wang Y, Yu Y, Li Y, Zhao S, Chen Y, Waqar AB, Fan J, Liu E. (2012). Expression of TRPV1 in rabbits and consuming hot pepper affects its body weight. Mol Biol Rep 39, 7583-7589
123. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. (2010). Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity (Silver Spring) 18, 780-787
124. Kang JH, Kim CS, Han IS, Kawada T, Yu R. (2007). Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett 581, 4389-4396
125. Chonpathompikunlert P, Wattanathorn J, Muchimapura S. (2010). Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem Toxicol 48, 798-802
126. Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. (2005). High dietary fat induces NADPH oxidase-Associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 191, 318-325
127. Ajuwon KM, Spurlock ME. (2005). Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135, 1841-1846
128. Weigert C, Brodbeck K, Staiger H, Kausch C, Machicao F, Haring HU, Schleicher ED. (2004). Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappa B. J Biol Chem 279, 23942-23952
129. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. (2003). Differential modulation of Toll like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res 44, 479-486
130. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. (2005). Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 174, 5390-5397
131. Fernandez-Real JM, Broch M, Vendrell J, Ricart W. (2003). Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26, 1362-1368
132. Yaqoob P, Knapper JA, Webb DH, Williams CM, Newsholme EA, Calder PC. (1998). Effect of olive oil on immune function in middle-Aged men. Am J Clin Nutr 67, 129-135
133. King DE, Egan BM, Geesey ME. (2003). Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92, 1335-1339
134. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, Marin C, Perez-Martinez P, Ruano J, Paniagua JA, Rodriguez F, Egido J, Perez-Jimenez F. (2009). Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis 204, e70-e76
135. Riediger ND, Othman RA, Suh M, Moghadasian MH. (2009). A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109, 668-679
136. He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R, Steffen L, Siscovick D, Tsai M, Herrington D. (2009). Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol 103, 1238-1243
137. Murakami K, Sasaki S, Takahashi Y, Uenishi K, Yamasaki M, Hayabuchi H, Goda T, Oka J, Baba K, Ohki K, Muramatsu K, Sugiyama Y. (2008). Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young Japanese women. Nutr Res 28, 309-314
138. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. (1999). Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 82, 216-221
139. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. (2003). NF-kappaBinhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-Alpha transcription. Am J Physiol Lung Cell Mol Physiol 284, L84-L89
140. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, Jebb SA. (2006). Additive benefits of longchain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 1535-1544
141. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, Quignard-Boulange A, Vidal H, Slama G, Clement K, Guerre-Millo M, Rizkalla SW. (2007). Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: A randomized controlled study. Am J Clin Nutr 86, 1670-1679
142. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D. (2007). Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 29, 321-329
143. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. (2007). The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70-80
144. Ciubotaru I, Lee YS, Wander RC. (2003). Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 14, 513-521
145. Eschen O, Christensen JH, De Caterina R, Schmidt EB. (2004). Soluble adhesion molecules in healthy subjects: A dose-response study using n-3 fatty acids. Nutr Metab Cardiovasc Dis 14, 180-185
146. Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, Arnesen H. (2005). Influence of long-Term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 81, 583-589
147. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM. (2006). Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49, 2109-2119
148. Yusof HM, Miles EA, Calder P. (2008). Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-Aged men. Prostaglandins Leukot Essent Fatty Acids 78, 219-228
149. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y. (2008). In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol 28, 2173-2179
150. Troseid M, Arnesen H, Hjerkinn EM, Seljeflot I. (2009). Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. Metabolism 58, 1543-1549
151. Herder C, Illig T, Rathmann W, Martin S, Haastert B, Muller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H, Group KS. (2005). Inflammation and type 2 diabetes: Results from KORA Augsburg. Gesundheitswesen 67(Suppl 1), S115-S121
152. Billiar TR, Bankey PE, Svingen BA, Curran RD, West MA, Holman RT, Simmons RL, Cerra FB. (1988). Fatty acid intake and Kupffer cell function: Fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 104, 343-349
153. Renier G, Skamene E, DeSanctis J, Radzioch D. (1993). Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler Thromb 13, 1515-1524
154. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. (1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116-122
155. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL. (1991). Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121, 547-555
156. Trebble TM, Wootton SA, Miles EA, Mullee M, Arden NK, Ballinger AB, Stroud MA, Burdge GC, Calder PC. (2003). Prostaglandin E2 production andTcell function after fish-oil supplementation: Response to antioxidant cosupplementation. Am J Clin Nutr 78, 376-382
157. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB. (2004). Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134, 1806-1811
158. Sadeghi S, Wallace FA, Calder PC. (1999). Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96, 404-410
159. Johansen O, Seljeflot I, Hostmark AT, Arnesen H. (1999). The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19, 1681-1686
160. Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I. (1998). Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest 28, 629-635
161. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC. (2001). Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183-1193
162. Wallace FA, Miles EA, Calder PC. (2003). Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr 89, 679-689
163. Kew S, Banerjee T, Minihane AM, Finnegan YE, Muggli R, Albers R, Williams CM, Calder PC. (2003). Lack of effect of foods enriched with plant-or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 77, 1287-1295
164. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. (2004). Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79, 674-681
165. Blok WL, Deslypere JP, Demacker PN, van der Ven-Jongekrijg J, Hectors MP, van der Meer JW, Katan MB. (1997). Pro-And anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur J Clin Invest 27, 1003-1008
166. Shen J, Arnett DK, Peacock JM, Parnell LD, Kraja A, Hixson JE, Tsai MY, Lai CQ, Kabagambe EK, Straka RJ, Ordovas JM. (2007). Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr 137, 1846-1851
167. Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, Calder PC. (2002). The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr 76, 454-459
168. Farooqui AA, Horrocks LA, Farooqui T. (2007). Modulation of inflammation in brain: A matter of fat. J Neurochem 101, 577-599
169. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. (2003). Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278, 14677-14687
170. Peterson LD, Jeffery NM, Thies F, Sanderson P, Newsholme EA, Calder PC. (1998). Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33, 171-180
171. Calder P. (2012). Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition of pharmacology. Br J Clin Pharmacol 75, 645-662
172. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. (2005). Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178-1184
173. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. (2006). Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91, 439-446
174. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, Schmidt EB. (2001). C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88, 1139-1142
175. Petersson H, Basu S, Cederholm T, Riserus U. (2008). Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: Longitudinal analyses in middle-Aged men. Br J Nutr 99, 1186-1189
176. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. (2003). Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108, 155-160
177. Raff M, Tholstrup T, Basu S, Nonboe P, Sorensen MT, Straarup EM. (2008). A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J Nutr 138, 509-514
178. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. (2005). Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135, 562-566
179. Baer DJ, Judd JT, Clevidence BA, Tracy RP. (2004). Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: Arandomized crossover study. Am J Clin Nutr 79, 969-973
180. Devore EE, Stampfer MJ, Breteler MM, Rosner B, Hee Kang J, Okereke O, Hu FB, Grodstein F. (2009). Dietary fat intake and cognitive decline in women with type 2 diabetes. Diabetes Care 32, 635-640
181. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. (1997). Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42, 776-782
182. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. (2004). Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62, 1573-1579
183. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Schneider J, Wilson RS. (2003). Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60, 194-200
184. Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ. (2004). Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62, 275-280
185. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer's disease. Arch Neurol 60, 940-946
186. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. (2005). Fish consumption and cognitive decline with age in a large community study. Arch Neurol 62, 1849-1853
187. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, Bruce-Keller AJ. (2010). Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 219, 25-32
188. Tanasescu M, Cho E, Manson JE, Hu FB. (2004). Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 79, 999-1005
189. Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. (2008). High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 40, 199-205
190. Chan DC, Watts GF, Barrett PH, Beilin LJ, Mori TA. (2002). Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 48, 877-883
191. Browning LM, Krebs JK, O'Connell MA, Mishra GD, Jebb SA. (2002). n-3 PUFA supplementation improves insulin sensitivity in a group of overweight women with an inflammatory phenotype. Proc Nutr Soc 61, 447-453
192. Calixto JB, Otuki MF, Santos AR. (2003). Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NFkappaB). Planta Med 69, 973-983
193. Hollman PC, Katan MB. (1999). Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol 37, 937-942
194. Kuhnau J. (1976). The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24, 117-191
195. Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276-1282
196. de Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, van Staveren WA, Katan MB. (1998). Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr 68, 60-65
197. Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. (2011). Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 34, 660-665
198. Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG. (2010). Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 58, 2095-2099
199. Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. (2011). Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 74, 664-669
200. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: Problems and promises. Mol Pharm 4, 807-818
201. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353-356
202. Percival SS, Vanden Heuvel JP, Nieves CJ, Montero C, Migliaccio AJ, Meadors J. (2012). Bioavailability of herbs and spices in humans as determined by ex vivo inflammatory suppression and DNA strand breaks. J Am Coll Nutr 31, 288-294
203. Bisht K, Wagner KH, Bulmer AC. (2010). Curcumin, resveratrol and flavonoids as anti-inflammatory, cytoand DNA-protective dietary compounds. Toxicology 278, 88-100
204. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H (1998)Wide distribution of [3H](-)-βepigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771-1776
205. Peng HW, Cheng FC, Huang YT, Chen CF, Tsai TH. (1998). Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 714, 369-374
206. Tsai TH, Chen YF. (2000). Simultaneous determination of cefazolin in rat blood and brain by microdialysis and microbore liquid chromatography. Biomed Chromatogr 14, 274-278
207. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. (2003). Interaction between flavonoids and the blood-brain barrier: In vitro studies. J Neurochem 85, 180-192
208. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. (2004). Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36, 592-604
209. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. (2004). Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 292, 1440-1446
210. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. (2004). Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44, 152-158
211. Gu Y, Luchsinger JA, Stern Y, Scarmeas N. (2010). Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis 22, 483-492
212. Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB, Rifai N, Willett WC, Hu FB. (2005). Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 82, 163-173
213. Panagiotakos DB, Dimakopoulou K, Katsouyanni K, Bellander T, Grau M, Koenig W, Lanki T, Pistelli R, Schneider A, Peters A. (2009). Mediterranean diet and inflammatory response in myocardial infarction survivors. Int J Epidemiol 38, 856-866
214. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. (2006). Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59, 912-921
215. Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. (2006). Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 63, 1709-1717
216. Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. (2007). Mediterranean diet and Alzheimer disease mortality. Neurology 69, 1084-1093
217. Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, Macaulay SL, Rowe CC, Szoeke C, Martins RN. (2012). Adherence to aMediterranean diet and Alzheimer's disease risk in an Australian population. Transl Psychiatry 2, e164
218. Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN. (2015). Dietary patterns and cognitive decline in an Australian study of ageing. Mol Psychiatry 20, 860-866
219. Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, Scarmeas N, Barberger-Gateau P. (2009). Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 302, 638-648
220. Cherbuin N, Anstey KJ. (2012). The Mediterranean diet is not related to cognitive change in a large prospective investigation: The PATH through life study. Am J Geriatr Psychiatry 20, 635-639
221. Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, Rastogi SS, Manor O, Pella D, Berry EM. (2002). Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): A randomised single-blind trial. Lancet 360, 1455-1461
222. Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. (2004). Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 80, 1012-1018
223. Mendez MA, Popkin BM, Jakszyn P, Berenguer A, Tormo MJ, Sanchez MJ, Quiros JR, Pera G, Navarro C, Martinez C, Larranaga N, Dorronsoro M, Chirlaque MD, Barricarte A, Ardanaz E, Amiano P, Agudo A, Gonzalez CA. (2006). Adherence to aMediterranean diet is associated with reduced 3-year incidence of obesity. J Nutr 136, 2934-2938
224. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. (2003). Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 2599-2608
225. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. (1999). Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 99, 779-785
226. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, van Staveren WA. (2004). Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The HALE project. JAMA 292, 1433-1439
227. Hickling S, Hung J, Knuiman M, Divitini M, Beilby J. (2008). Are the associations between diet and C-reactive protein independent of obesity'. Prev Med 47, 71-76
228. Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, Hu FB. (2001). Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 73, 61-67
229. Nettleton JA, Steffen LM, Mayer-Davis EJ, Jenny NS, Jiang R, Herrington DM, Jacobs DR Jr. (2006). Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 83, 1369-1379
230. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. (2007). Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr 137, 992-998
231. Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB. (2004). Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 80, 1029-1035
232. Nettleton JA, Matijevic N, Follis JL, Folsom AR, Boerwinkle E. (2010). Associations between dietary patterns and flow cytometry-measured biomarkers of inflammation and cellular activation in the Atherosclerosis Risk in Communities (ARIC) Carotid Artery MRI Study. Atherosclerosis 212, 260-267
233. Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN. (2015). Dietary patterns and cognitive decline in an Australian study of ageing. Mol Psychiatry 20, 860-866
234. Manjeet KR, Ghosh B. (1999). Quercetin inhibits LPSinduced nitric oxide and tumor necrosis factor-Alpha production in murine macrophages. Int J Immunopharmacol 21, 435-443
235. Wadsworth TL, Koop DR. (1999). Effects of the wine polyphenolics quercetin and resveratrol on proinflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 57, 941-949
236. Geng Y, Zhang B, Lotz M. (1993). Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151, 6692-6700
237. Wadsworth TL, McDonald TL, Koop DR. (2001). Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-Alpha. Biochem Pharmacol 62, 963-974
238. Lyu SY, Park WB. (2005). Production of cytokine and NO by RAW264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch Pharm Res 28, 573-581
239. Soliman KF, Mazzio EA. (1998). In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 218, 390-397
240. Zheng LT, Ock J, Kwon BM, Suk K. (2008). Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8, 484-494
241. Murakami Y, Shoji M, Hanazawa S, Tanaka S, Fujisawa S. (2003). Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor kappa B activation and inflammatory cytokine expression in macrophages. Biochem Pharmacol 66, 1061-1066
242. Jang S, Kelley KW, Johnson RW. (2008). Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A 105, 7534-7539
243. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JP. (2009). The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484, 100-109
244. Lau FC, Bielinski DF, Joseph JA. (2007). Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-Activated BV2 microglia. J Neurosci Res 85, 1010-1017
245. Chan MM, Fong D, Ho CT, Huang HI. (1997). Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 54, 1281-1286
246. Zheng LT, Ryu GM, Kwon BM, Lee WH, Suk K. (2008). Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: Inhibition of microglial neurotoxicity. Eur J Pharmacol 588, 106-113
247. Gunawardena D, Shanmugam K, Low M, Bennett L, Govindaraghavan S, Head R, Ooi L, Munch G. (2014). Determination of anti-inflammatory activities of standardised preparations of plant-And mushroom-based foods. Eur J Nutr 53, 335-343
248. Surh YJ. (2002). Anti-Tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol 40, 1091-1097
249. Browning LM. (2003). n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc Nutr Soc 62, 447-453